Literature DB >> 16215392

Mechanisms of decreased intestinal epithelial proliferation and increased apoptosis in murine acute lung injury.

Kareem D Husain1, Paul E Stromberg, Cheryl A Woolsey, Isaiah R Turnbull, W Michael Dunne, Pardis Javadi, Timothy G Buchman, Irene E Karl, Richard S Hotchkiss, Craig M Coopersmith.   

Abstract

OBJECTIVES: The aim of this study was to determine the effects of acute lung injury on the gut epithelium and examine mechanisms underlying changes in crypt proliferation and apoptosis. The relationship between severity and timing of lung injury to intestinal pathology was also examined.
DESIGN: Randomized, controlled study.
SETTING: University research laboratory.
SUBJECTS: Genetically inbred mice.
INTERVENTIONS: Following induction of acute lung injury, gut epithelial proliferation and apoptosis were assessed in a) C3H/HeN wild-type and C3H/HeJ mice, which lack functional Toll-like receptor 4 (n = 17); b) C57Bl/6 mice that received monoclonal anti-tumor necrosis factor-alpha or control antibody (n = 22); and c) C57Bl/6 wild-type and transgenic mice that overexpress Bcl-2 in their gut epithelium (n = 21). Intestinal epithelial proliferation and death were also examined in animals with differing degrees of lung inflammation (n = 24) as well as in a time course analysis following a fixed injury (n = 18).
MEASUREMENTS AND MAIN RESULTS: Acute lung injury caused decreased proliferation and increased apoptosis in crypt epithelial cells in all animals studied. C3H/HeJ mice had higher levels of proliferation than C3H/HeN animals without additional changes in apoptosis. Anti-tumor necrosis factor-alpha antibody had no effect on gut epithelial proliferation or death. Overexpression of Bcl-2 did not change proliferation despite decreasing gut apoptosis. Proliferation and apoptosis were not correlated to severity of lung injury, as gut alterations were lost in mice with more severe acute lung injury. Changes in both gut epithelial proliferation and death were apparent within 12 hrs, but proliferation was decreased 36 hrs following acute lung injury while apoptosis returned to normal.
CONCLUSIONS: Acute lung injury causes disparate effects on crypt proliferation and apoptosis, which occur, at least in part, through differing mechanisms involving Toll-like receptor 4 and Bcl-2. Severity of lung injury does not correlate with perturbations in proliferation or death in the gut epithelium, and acute lung injury-induced changes in intestinal epithelial proliferation persist longer than those in apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16215392      PMCID: PMC1317567          DOI: 10.1097/01.ccm.0000182797.89252.a3

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  43 in total

1.  Role of apoptosis in Pseudomonas aeruginosa pneumonia.

Authors:  R S Hotchkiss; W M Dunne; P E Swanson; C G Davis; K W Tinsley; K C Chang; T G Buchman; I E Karl
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

Review 2.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 3.  Proliferation, cell cycle and apoptosis in cancer.

Authors:  G I Evan; K H Vousden
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice.

Authors:  Craig M Coopersmith; Katherine C Chang; Paul E Swanson; Kevin W Tinsley; Paul E Stromberg; Timothy G Buchman; Irene E Karl; Richard S Hotchkiss
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

5.  Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide.

Authors:  M T Abreu; P Vora; E Faure; L S Thomas; E T Arnold; M Arditi
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

6.  Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation.

Authors:  Lucas Liaudet; Pál Pacher; Jon G Mabley; László Virág; Francisco G Soriano; György Haskó; Csaba Szabó
Journal:  Am J Respir Crit Care Med       Date:  2002-02-01       Impact factor: 21.405

7.  TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells.

Authors:  Maria T Abreu; Elizabeth T Arnold; Lisa S Thomas; Rivkah Gonsky; Yuehua Zhou; Bing Hu; Moshe Arditi
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

8.  Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis.

Authors:  Craig M Coopersmith; Paul E Stromberg; W Michael Dunne; Christopher G Davis; Daniel M Amiot; Timothy G Buchman; Irene E Karl; Richard S Hotchkiss
Journal:  JAMA       Date:  2002-04-03       Impact factor: 56.272

9.  The role of poly(ADP-ribose) synthetase inhibition in preventing endotoxemia-induced intestinal epithelial apoptosis.

Authors:  Ismail Cinel; Kanso Buyukafsar; Leyla Cinel; Ayşe Polat; Sebnem Atici; Lulufer Tamer; Ugur Oral
Journal:  Pharmacol Res       Date:  2002-08       Impact factor: 7.658

10.  Role of TNF-alpha in gut mucosal changes after severe burn.

Authors:  Marcus Spies; Vicky L Chappell; Mohan R Dasu; David N Herndon; James C Thompson; Steven E Wolf
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-09       Impact factor: 4.052

View more
  9 in total

1.  Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestine.

Authors:  D Vyas; C M Robertson; P E Stromberg; J R Martin; W M Dunne; C W Houchen; T A Barrett; A Ayala; M Perl; T G Buchman; C M Coopersmith
Journal:  Histol Histopathol       Date:  2007-06       Impact factor: 2.303

Review 2.  Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness.

Authors:  Jessica A Clark; Craig M Coopersmith
Journal:  Shock       Date:  2007-10       Impact factor: 3.454

3.  Biographical Feature: William Michael Dunne, Jr., Ph.D.

Authors:  Betty A Forbes
Journal:  J Clin Microbiol       Date:  2017-09-06       Impact factor: 5.948

4.  Intestine-specific overexpression of IL-10 improves survival in polymicrobial sepsis.

Authors:  Saju Rajan; Dinesh Vyas; Andrew T Clark; Cheryl A Woolsey; Jessica A Clark; Richard S Hotchkiss; Timothy G Buchman; Craig M Coopersmith
Journal:  Shock       Date:  2008-04       Impact factor: 3.454

5.  Enterocyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis.

Authors:  Jessica A Clark; Heng Gan; Alexandr J Samocha; Amy C Fox; Timothy G Buchman; Craig M Coopersmith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-01       Impact factor: 4.052

Review 6.  A review of the molecular mechanisms of chemically induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer.

Authors:  Mark J Hoenerhoff; Hue Hua Hong; Tai-vu Ton; Stephanie A Lahousse; Robert C Sills
Journal:  Toxicol Pathol       Date:  2009-12       Impact factor: 1.902

7.  The anesthetic agent sevoflurane attenuates pulmonary acute lung injury by modulating apoptotic pathways.

Authors:  L Wang; Y Ye; H B Su; J P Yang
Journal:  Braz J Med Biol Res       Date:  2017-02-20       Impact factor: 2.590

8.  Chronic alcohol ingestion increases mortality and organ injury in a murine model of septic peritonitis.

Authors:  Benyam P Yoseph; Elise Breed; Christian E Overgaard; Christina J Ward; Zhe Liang; Maylene E Wagener; Daniel R Lexcen; Elizabeth R Lusczek; Greg J Beilman; Eileen M Burd; Alton B Farris; David M Guidot; Michael Koval; Mandy L Ford; Craig M Coopersmith
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

Review 9.  Is boosting the immune system in sepsis appropriate?

Authors:  Jean-Marc Cavaillon; Damon Eisen; Djilalli Annane
Journal:  Crit Care       Date:  2014-03-24       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.